Business & Investment

Pfizer is on track for a US vaccine booster and Modana is behind, Forch told Reuters.

© Reuters. File Photo: Dr. Anthony Fauci, Director of the National Institute for Allergic Infectious Diseases, will speak at a hearing of the Senate Health, Education, Labor and Pension Commission on July 20 at the Senate Office Building in Washington, DC, USA. bottom.

Rafael Satter

Washington (Reuters)-Dr. Anthony Fauci, a top US infectious disease expert, said on Sunday that authorities are likely to soon allow regulators to receive COVID-19 vaccine booster shots. Pfizer (NYSE :), but Modana (NASDAQ :) Boosters may take a little longer.

Asked at CBS’s “Face the Nation” about President Joe Biden’s goal of giving booster shots starting September 20, Forch said plans remain “in some respects.”

But he said Pfizer-BioNTech submitted the necessary data on booster shots to the Food and Drug Administration (FDA), but Moderna has not yet completed the process. Forch said he wanted to administer both vaccines when booster administration was initiated, but if Moderna did not complete the process by September 20, Moderna booster would be administered later. Will be done.

Moderna and the FDA did not immediately return an email asking for comment. In a statement released Wednesday, Moderna said it had “started submitting” booster data to the FDA.

How to Manage Boosters (or Whether) 03 COVID-19 has emerged as a thorny issue as it continues to kill unvaccinated people around the world

Last month, the Biden administration announced that it would begin providing boosters to Americans by September 20th. https: // -19-Booster-Needed-2021-09-03 FDA and US Centers for Disease Control and Prevention usually do that To determine such issues, current and former FDA scientists and members of the CDC Advisory Board told Reuters.

Scientists still discuss how much additional immune boosters will be offered, as well as those at high risk of severe illness, and whether all Americans need to get another shot. I am.

On Sunday, Fauci emphasized that both boosters were assumed to be safe, but the FDA and other officials would study the data to confirm.

“When you’re working on allowing Americans to intervene, you want to make sure you’re absolutely confident,” he said.

Disclaimer: Fusion media We inform you that the data contained on this website is not necessarily real-time or accurate. All CFDs (stocks, indices, futures) and forex prices are offered by market makers, not exchanges, so prices may not be accurate and may differ from actual market prices. In other words, price is an indicator and is not suitable for trading purposes. Therefore, Fusion Media is not responsible for any transactional losses that may occur as a result of using this data.

Fusion media Alternatively, anyone involved in Fusion Media will not be liable for any loss or damage resulting from relying on the data, quotes, charts, trading signals and other information contained on this website. Please be fully informed about the risks and costs associated with financial market transactions. This is one of the most risky forms of investment possible.

Pfizer is on track for a US vaccine booster and Modana is behind, Forch told Reuters. Pfizer is on track for a US vaccine booster and Modana is behind, Forch told Reuters.

Back to top button